Compare Alcon AG (ALC) vs Amazon.com Inc (AMZN) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
Alcon AG vs Amazon.com Inc — how do they compare? Alcon AG trades at $66.85 (market cap $32.69B), while Amazon.com Inc trades at $241.6 (market cap $2.65T). The key difference: Amazon.com Inc is far larger — about 81.1× Alcon AG's market cap, and Alcon AG pays a 0.54% dividend while Amazon.com Inc pays none. Which is the better fit depends on your goals.
| ALC | AMZN | |
|---|---|---|
Market Cap | $32.69B | $2.65T |
Sector | Health | Consumer Cyclical |
52-Week High | $92.22 | $274.95 |
52-Week Low | $62.02 | $198.79 |
Enterprise Value | $36.28B | $2.71T |
Dividend Yield | 0.54% | — |
Volume | — | 3,931,282 |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ALC trades at $66.87, down 4.01% on the day, amid a mixed technical and fundamental backdrop. The stock exhibits a bullish technical signal overall, with moving averages supporting a positive trend, while oscillators remain neutral. Fundamentally, revenue growth is steady, reaching $10.40 billion in 2025, though net income margin compressed to 7.7%. Recent news highlights product innovation, including a collaboration with RxSight for adjustable PCIOLs, signaling ongoing R&D investment. Analyst sentiment is predominantly positive, with a consensus price target of $86.00 implying significant upside.
The outlook for ALC is cautiously optimistic, driven by new product launches and strategic partnerships that may fuel growth. However, risks include competitive pressures, macroeconomic headwinds, and margin compression. With a P/E of 40.92, the valuation appears rich relative to historical norms, requiring strong earnings delivery to justify current levels. Investors should weigh robust analyst buy ratings against execution risks and market volatility.
Amazon (AMZN) trades at $242.55, down 0.66% on the day, with a bullish technical outlook supported by moving averages. The company reported strong revenue growth to $716.92 billion in 2025, with net income reaching $77.67 billion and a profit margin of 10.83%. Recent news highlights CEO Andy Jassy's optimistic outlook on AWS and AI chip capacity, driving positive sentiment. The stock is near key support at $243, with resistance at $248.
Outlook remains positive with 88.3% analyst buy ratings and a $321.11 consensus price target, implying significant upside. Risks include intense competition in e-commerce and cloud services, high valuation multiples, and macroeconomic pressures. Earnings growth and AI-driven AWS expansion are key catalysts, but investors should monitor execution and capex trends.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Alcon AG
Alcon, headquartered in Fort Worth, Texas, is the global eyecare leader with a diverse portfolio in ophthalmology including contact lenses, eye drops, surgical equipment, and related surgical products. Novartis purchased Alcon from Nestle in 2010 and, following nine years as a Novartis subsidiary, the company was spun off as a public company in April 2019. The company reports five distinct segments: implantables (16% of revenue), consumables (31%), equipment (9%), contact lenses (27%), and ocular health (17%). The company is geographically diversified, with only about 40% of revenue from the U.S. market, and the firm has a strong presence in the European Union and Japan.
Read more on ALC →About Amazon.com Inc
Amazon.com, Inc. is an online retailer that offers a wide range of products. The Company products include books, music, computers, electronics and numerous other products. Amazon offers personalized shopping services, Web-based credit card payment, and direct shipping to customers. Amazon also operates a cloud platform offering services globally.
Read more on AMZN →
